NZ's Fisher & Paykel Healthcare slips, Morningstar says co overvalued

Fisher & Paykel Healthcare

02/06/2026 01:20

Updates
** Shares of Fisher & Paykel Healthcare FPH.NZ fall as much as 1.1% to NZ$36.9, their lowest level since May 26
** Morningstar raises its fair value estimate for FPH to NZ$30.5, reflecting adjustments for the time value of money
** Investment research firm says shares are overvalued, with the market appearing 'too optimistic' about the pace of revenue growth
** Trims its FY2027 payout ratio forecast to 65% from 75%, implying a 12% reduction in dividend to NZ$0.59
** However, Morningstar will revert to a 75% payout ratio assumption upon completion of its fifth facility at the East Tāmaki campus and final land payment at its Karaka site
** YTD, stock down ~2%

(Reporting by Anjali Singh in Bengaluru)
((anjali.singh2@thomsonreuters.com;))